Psych Congress

Lithium: A Lifesaving Tool in Bipolar I Disorder Even among patients we often consider the hardest to treat - those with bipolar I disorder and comorbid substance use - lithium continues to show remarkable benefits. As highlighted in this clip from a #PsychCongress2025 Difficult Medicines session, the greatest impact on survival and stability occurs in patients maintained on lithium, not valproate. It’s a powerful reminder that the right treatment can make a life-saving difference. #PsychCongress #BipolarDisorder #Psychiatry #MoodDisorders #Lithium #MentalHealthTreatment

This Thanksgiving, we’re giving thanks for you - the dedicated mental health professionals making a difference every day. 🧡 As you take time to recharge, remember to also invest in yourself. The Psych Congress portfolio offers year-round opportunities to learn, connect, and grow with a community that shares your passion for mental health care. 🧠 Discover education opportunities that keep your mind - and your practice - thriving. #PsychCongress #Thanksgiving #MentalHealthEducation #ProfessionalGrowth #mentalhealth

Honoring Survivors. Offering Hope. Today is International Survivors of Suicide Loss Day. 💙 Today, on International Survivors of Suicide Loss Day, we pause to honor the strength of individuals who have experienced the profound heartbreak of losing someone to suicide. It’s a day of both remembrance and connection. Your pain is valid. Your journey matters. Your voice matters. Learn more about International Survivors of Suicide Loss Day here: https://hubs.ly/Q03S3yRQ0

🧠💤 How Antipsychotic Medications Affect Sleep Sleep plays a critical role in the recovery and stability of patients with schizophrenia - but the relationship between antipsychotic medications and sleep isn’t always straightforward. In this insightful video, our Psych Congress Co-Chair, Greg Mattingly, MD, explores how these medications can both restore and disrupt sleep, and why clinicians must look beyond sedation to consider factors like daytime fatigue, fragmented sleep, and sleep apnea - which affects up to 40% of patients with schizophrenia. Watch the video here: https://hubs.ly/Q03S9_Wg0 #psychiatry #mentalhealth #schizophrenia #medication #sleep #psychcongress #education

While data show that long-acting injectables (LAIs) reduce hospitalization and relapse in patients with schizophrenia, these treatment options still remain underused in clinical practice. In this video, filmed at #PsychCongress2025 in San Diego, Brittany Albright MD, MPH, explores common barriers that have inhibited the wider spread adoption of LAIs for schizophrenia treatment. From tackling pervasive stigma to addressing practical concerns, Dr Albright offers several ways clinicians can reframe their understanding of these long-acting treatment options in this insightful discussion. Watch the video: https://hubs.ly/Q03RCl8B0

See why year after year, thousands of mental health professionals return to Psych Congress. New ideas, new data, new enthusiasm - it's all waiting for you at #PsychCongress2026.

Happy Halloween to our #PsychCongressFamily! Throwing it back to last year's Networking Event in Boston. 🎃

Looking for ADHD resources that keep up? Partner Spotlight is constantly updated with new content, patient stories, clinical insights, back-to-school tools, and more. Log in, look around, and come back often. There's always something new. https://hubs.ly/Q03Qfzcy0

We are thrilled to share the news that Craig Chepke, MD, DFAPA has been appointed as Chief Medical Officer for Psych Congress. We are grateful for the continuous and highly impactful contributions that Dr. Chepke makes to our educational offerings and community. Join us in congratulating him on this well-deserved accomplishment! 👏 #PsychCongress #mentalhealth #mentalhealthcare #CME #continuingeducation